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The Leishmania donovani secretome  <p>Analysis of Leishmania-conditioned medium resulted in the identification of 151 proteins apparently secreted by the parasitic proto- zoan Leishmania donovani and suggested a vesicle-based secretion system.</p>
Abstract
Background: Leishmania and other intracellular pathogens have evolved strategies that support
invasion and persistence within host target cells. In some cases the underlying mechanisms involve
the export of virulence factors into the host cell cytosol. Previous work from our laboratory
identified one such candidate leishmania effector, namely elongation factor-1α, to be present in
conditioned medium of infectious leishmania as well as within macrophage cytosol after infection.
To investigate secretion of potential effectors more broadly, we used quantitative mass
spectrometry to analyze the protein content of conditioned medium collected from cultures of
stationary-phase promastigotes of Leishmania donovani, an agent of visceral leishmaniasis.
Results: Analysis of leishmania conditioned medium resulted in the identification of 151 proteins
apparently secreted by L. donovani. Ratios reflecting the relative amounts of each leishmania protein
secreted, as compared to that remaining cell associated, revealed a hierarchy of protein secretion,
with some proteins secreted to a greater extent than others. Comparison with an in silico approach
defining proteins potentially exported along the classic eukaryotic secretion pathway suggested that
few leishmania proteins are targeted for export using a classic eukaryotic amino-terminal secretion
signal peptide. Unexpectedly, a large majority of known eukaryotic exosomal proteins was
detected in leishmania conditioned medium, suggesting a vesicle-based secretion system.
Conclusion: This analysis shows that protein secretion by L. donovani is a heterogeneous process
that is unlikely to be determined by a classical amino-terminal secretion signal. As an alternative, L.
donovani appears to use multiple nonclassical secretion pathways, including the release of exosome-
like microvesicles.
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Background
Leishmania spp. are the causative agents of a group of tropi-
cal and subtropical infectious diseases termed the leishmani-
ases. These infections disproportionately affect poorer
peoples in developing areas of the world. Because of the debil-
itating and disfiguring results of infection, these diseases are
a great barrier to socioeconomic progress in endemic areas.
As of 2001, it was estimated that 12 million people worldwide
have been infected with leishmania, and 2 million new cases
are believed to occur each year [1]. Recent environmental
changes such as urbanization, deforestation, and new irriga-
tion schemes have expanded endemic regions and have led to
sharp increases in the number of reported cases [2-4]. In
addition, visceral leishmaniasis is establishing itself in previ-
ously unaffected areas by piggy-backing on the spread of the
HIV epidemic [5]. Leishmania co-infection with HIV has
become a serious global health threat. The two infections are
involved in a deadly synergy, because leishmania infection
exacerbates the immunocompromised state of infected indi-
viduals, thereby promoting HIV replication and resulting in
earlier onset of AIDS [6]. The combination of HIV co-infec-
tion, expansion of endemic regions, and evolving drug resist-
ance [7] has created great need for more effective anti-
leishmanial drugs and other control measures. Progress in
controlling the leishmaniases requires improved appreciation
of the biology of the parasite to allow novel treatment strate-
gies to be designed.
Members of the genus Leishmania are digenetic protozoans.
The organisms exist either as flagellated, motile promastig-
otes within the alimentary canal of their phlebotomine sand-
fly vector or as nonmotile amastigotes that reside within
phagolysosomes of mammalian mononuclear phagocytes.
Promastigote surface coat constituents have been the focus of
considerable interest [8-10], and many of these - including
glycoproteins, proteoglycans, and glycolipids - have been
shown to play protective roles [8,11,12]. Surface-associated
molecules are considered to make up the vast majority of
leishmania secreted material [9]. Through these studies, it
has become evident that there are a number of unusual fea-
tures that typify exocytosis by this group of trypanosomatids.
For example, in these highly polarized cells, regulated secre-
tion is thought to occur solely at the flagellar pocket, a deep
invagination of the plasma membrane from which the single
flagellum of leishmania emerges [9,13]. Leishmania are
known to synthesize and traffic most surface molecules, such
as lipophosphoglycan and leishmanolysin GP63, along the
classical endoplasmic reticulum-Golgi apparatus-plasma
membrane pathway [9]. As mentioned, these surface mole-
cules are ultimately delivered to the flagellar pocket, and it is
thought that the pocket retains its role as the primary if not
sole site of secretion in nonflagellated amastigotes [9]. Thus
far, no leishmania candidate virulence factors have been
shown to traffic through the flagellar pocket. This is not sur-
prising, however, given that no ultrastructural work has
accompanied descriptions of leishmania candidate virulence
factors, and little attention has been paid to their intracellular
or extracellular trafficking pathways.
Whether leishmania use a classical amino-terminal signal
sequence peptide to direct the export of most secreted pro-
teins through the flagellar pocket or a different mechanism is
unclear. Two leishmania surface glycoproteins, a proteophos-
phoglycan and GP63, are initially synthesized with a cleava-
ble amino-terminal signal sequence [9]. However, the vast
majority of characterized leishmania secreted proteins have
no identifiable secretion signal sequence, with the exception
of those that are initially membrane bound [9,14,15]. The lack
of a clear amino-terminal secretion signal sequence among
the majority of characterized leishmania secreted proteins
suggests the existence of important nonclassical pathways of
secretion.
Despite the potential importance of protein secretion by
leishmania, only a small number of leishmania proteins have
been examined in detail from this perspective [14,16-18]. Ide-
ally, one would like to know the identities of all of the compo-
nents of any complex system in order to fully comprehend
functionality. Consequently, we set out to identify all, or as
many as possible, of the proteins secreted by leishmania. To
this end, we designed a quantitative proteomic approach
based on SILAC (stable isotopic labeling of amino acids in
culture) [19-21]. SILAC involves culturing cells with either
normal isotopic abundance amino acids or with stable iso-
tope-enriched amino acids (for instance, L-arginine versus
13C6-L-arginine) until essentially all proteins of the cell are
labeled. The two populations or samples to be compared are
then mixed and analyzed by nanoflow liquid chromatogra-
phy-tandem mass spectrometry (LC-MS/MS). We used this
approach to analyze the extent to which any given leishmania
protein was secreted into promastigote conditioned medium
( C m )  b y  r e l a t i n g  i t  t o  t h e  level of the same protein that
remained cell associated (CA). In this report, we identified
358 proteins in combined Cm/CA mixtures from Leishmania
donovani and, based on a quantitative analysis, we conclude
that 151 were actively secreted. The general properties of the
identified secreted proteins allowed us to postulate potential
mechanisms of secretion as well as functional roles within the
context of infection.
Results
Leishmania conditioned medium contains a 
multiplicity of enriched proteins
The main objective of this study was to characterize as com-
prehensively as possible the proteins actively secreted by pro-
mastigotes of L. donovani into culture medium. Before
proceeding with the SILAC and LC-MS/MS analysis, we
sought to develop a system in which we were confident that
the proteins we were detecting in Cm were not artifacts and
were in fact present due to bona fide secretion. Previous
investigations of protein secretion by leishmania werehttp://genomebiology.com/2008/9/2/R35 Genome Biology 2008,     Volume 9, Issue 2, Article R35       Silverman et al. R35.3
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hampered by the presence of degradation products and by the
requirement of the cells for serum [14,22]. In light of these
complexities, we included a nontoxic protease inhibitor, soy
bean trypsin inhibitor, in the promastigote culture medium
during collection and isolation of Cm to minimize degrada-
tion of secreted proteins by proteases. Secondly, we reduced
Cm collection time to 6 hours or less in order to allow culture
of promastigotes under serum-free conditions. Pulse-chase
labeling of leishmania with 35S-methionine followed by isola-
tion of serum-free Cm showed clearly that leishmania
secreted numerous proteins (Figure 1a). Here, an equal
number of trichloroacetic acid-precipitated counts/minute of
Cm and whole cell lysate (WCL) were analyzed, allowing us to
compare directly the intensities of protein bands from Cm
and WCL. The results show that some of the leishmania-
secreted proteins (arrows in Figure 1a) were clearly enriched
in the Cm. It is also important to note that the clearly distinct
protein separation patterns of leishmania Cm and WCL indi-
cate that the proteins detected in Cm were unlikely to be arti-
facts present due to lysis of cells during culture or processing
(Figure 1a).
To control further for the possibility of false positive protein
detection in Cm caused by inadvertent lysis of promastigotes
either spontaneously (due to programmed cell death) or dur-
ing isolation of Cm, using an enzymatic assay we measured
the amount of cytosolic marker glucose 6-phosphate dehy-
drogenase (G6PD) [23] present in Cm. The total amount of
G6PD activity detected in Cm was compared with activities
found to be associated with serial dilutions of the total mass
of promastigotes that was used to generate the Cm. As shown
i n  F i g u r e  1 b ,  t h e  a m o u n t  o f  G 6 P D  d e t e c t e d  i n  C m  n e v e r
exceeded the total enzyme activity that was associated with
5% of the promastigotes used to generate the Cm. Notably,
there was also no difference in the amount of G6PD detected
in Cm collected from promastigotes that had been grown in
either stable isotope or normal isotopic abundance culture
medium (data not shown) during the SILAC analysis
described below.
Quantitative mass spectrometry identifies a wide array 
of leishmania-secreted proteins
Serum-free leishmania Cm collected from stationary phase
promastigotes was fractionated either by one-dimension
SDS-PAGE or by in-solution isoelectric focusing and analyzed
Leishmania Cm contains enriched proteins and is minimally contaminated by incidental cell lysis Figure 1
Leishmania Cm contains enriched proteins and is minimally contaminated by incidental cell lysis. (a) Leishmania promastigotes were metabolically labeled, 
as described in Materials and methods. Conditioned medium (Cm) from labeled cells and the cells themselves were collected in parallel, and the proteins 
present in the Cm and corresponding whole cell lysate (WCL) of promastigotes were precipitated in 10% trichloroacetic acid (TCA). Equal numbers of 
TCA-precipitated counts/minute of Cm and WCL were fractionated on a 5% to 20% gradient polyacrylamide gel. Arrows indicate proteins specifically 
enriched in leishmania Cm. The autoradiograph shown is representative of three independent experiments. (HMW) High molecular weight marker. (b) To 
control for inadvertent lysis of organisms during collection of Cm, glucose-6-phosphate dehydrogenase (G6PD) activity in Cm collected from isotopically 
labeled and nonlabeled cells was measured as described in Materials and methods and compared with the activity associated with deliberately lysed 
promastigotes. The data shown are the means of measurements from three independent experiments. 0.01 units of G6PD were assayed as a control in 
each experiment. The asterisks shown indicate a significance difference when compared with Cm (P < 0.001), calculated by one-way analysi of variance 
followed by Bonferroni's correction for multiple comparisons (GraphPad Prism 4.0).
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by LC-MS/MS using a linear trapping quadrupole-Fourier
transform hybrid mass spectrometer (see Materials and
methods, below). We set three criteria that had to be met for
any protein detected by mass spectrometry to be included in
the leishmania 'secretome'. First, we only considered proteins
to be identified if at least two unique tryptic peptide
sequences from that protein were detected (see Materials and
methods for peptide criteria limits). Second, we required a
particular protein to be observed in at least three out of four
independent experiments. This resulted in the identification
of 358 proteins (listed in Additional data file 1) in the pooled
Cm and CA samples, with an estimated false discovery rate of
less than one protein in 200. Interestingly, by these criteria
we did not detect G6PD in any of the LC-MS/MS analyses,
probably because the amount of G6PD was below the detec-
tion limit of the mass spectrometer.
The method of preparation of Cm for LC-MS/MS analysis did
not provide sufficient amounts of protein to allow reliable use
of standard methods for measuring total protein concentra-
tion (see Materials and methods, below), so we estimated the
protein content of Cm samples from an initial LC-MS/MS
analysis and mixed these with an equal amount of oppositely
labeled CA protein. Because this method of equalization is
imprecise, we normalized all Cm/CA ratios within an experi-
ment to histone H2B (GeneDB:LmjF19.0050). H2B was con-
sistently detected in Cm, most likely as a result of both general
cell lysis and apoptosis [24,25]. After normalization, the val-
ues were loge transformed (Additional data file 2) and Cm/CA
ratios for all identified proteins were calculated as the mean
Cm/CA ratio for all peptides from that protein across all
experiments (Additional data file 2) [26,27]. These SILAC
ratios reflected the degree of enrichment of individual protein
species in leishmania Cm, and a frequency distribution is
shown in Figure 2. Across all experiments the overall mean ±
standard deviation Cm/CA value for the 358 proteins was 1.35
± 0.85 (Figure 2).
Quantitation of leishmania secreted proteins in Cm Figure 2
Quantitation of leishmania secreted proteins in Cm. Conditioned medium (Cm)/cell associated (CA) ratios from each of four independent analyses were 
normalized to the ratio for that of histone H2B followed by log normal (Ln) transformation (see Additional data file 2). Mean values across the four 
experiments for each protein identity were calculated as described in Materials and Methods. GraphPad Prism 4.0 was then used to calculate the mean and 
standard deviation (SD) of all Cm/CA values for all proteins found in leishmania Cm (mean = 1.39, SD = 0.85). The same program generated a frequency 
distribution of the mean Cm/CA values based on the relative frequency of each value within the dataset. Proteins with mean Cm/CA values greater than 2 
SDs (1.7; solid black horizontal line) above the value for histone H2B were considered to be members of the secretome. Mean Ln transformed ratios of 
protein abundance (Cm/CA) where identities lying above the black line are actively secreted, and values falling below the dotted line are likely present due 
to apoptosis or lysis. X-axis numbers correspond to each protein identity, with 358 in total. The mean and SD from at least three measurements for each 
protein are shown.
Hist. H2B
cutoff
50 100 150 200 250 300 350
-3
-2
-1
1
2
3
4
5
6
Hist. H2B
cutoff
M
e
a
n
 
L
n
 
T
r
a
n
s
f
o
r
m
e
d
 
r
a
t
i
o
 
v
a
l
u
e
shttp://genomebiology.com/2008/9/2/R35 Genome Biology 2008,     Volume 9, Issue 2, Article R35       Silverman et al. R35.5
Genome Biology 2008, 9:R35
We used the Cm/CA ratio of histone H2B to define the third
criterion for inclusion in the secretome. We considered leish-
mania proteins with a mean Cm/CA peptide ratio at least two
standard deviations (1.7) above the ratio for histone H2B
(after transformation = 0) to be actively secreted by leishma-
nia (Figure 2, solid line). In choosing this rather conservative
yet arbitrary cut-off, we reasoned that if H2B was representa-
tive of proteins externalized by apoptosis then, by allowing a
significant margin of error around it, the proteins (number-
ing 151 in total) with Cm/CA ratios of 1.7 or greater were likely
to be bona fide secreted proteins. This conservative approach
provided a high level of specificity for 'secretion' at the
expense of sensitivity.
We used Western blotting to examine a select group of pro-
teins in paired Cm and CA samples to determine the extent to
which this orthogonal method of detection would correlate
with the SILAC/mass spectrometry analysis. Here we exam-
ined four proteins: heat shock protein (HSP)70, with a Cm/
CA value of 1.86, above the cut-off of histone H2B plus two
standard deviations (or +1.70); HSP83/HSP90, with a Cm/
CA ratio of 1.50 falling just below the cut-off; elongation fac-
tor-1α (EF-1α) with a ratio of 0.69; and secreted acid phos-
phatase (SacP), which was not detected by LC-MS/MS. As
shown in Figure 3, SAcP was detected as a dispersed band in
Cm, but it was completely absent from the aliquots of WCL
analyzed (lanes 1 and 2). Both HSP70 and HSP90 were also
clearly enriched in Cm, with HSP70 to a greater extent than
HSP90 (compare Cm with WCL lane 2). On the other hand,
the bulk of EF-1α was retained intracellularly (Figure 3). This
qualitative analysis indicated that the SILAC/LC-MS/MS
results correlated closely with conventional protein detection
by Western blotting in respect of providing a semiquantita-
tive estimate of protein secretion by leishmania. Additionally,
these findings indicated that the arbitrary third criterion for
inclusion in the secretome was both valid and in fact highly
rigorous, because HSP90 - a protein falling just below the
secretome cut-off (Cm/CA of 1.7; Figure 2) - was clearly found
to be enriched in Cm by Western blotting (again compare Cm
with WCL lane 2).
The results for SAcP both by mass spectrometry and Western
blotting were of particular interest and appeared to be a spe-
cial case. Whereas this ecto-enzyme, which was previously
reported to have an amino-terminal secretion signal [28], was
highly enriched in Cm (Figure 3), its absence from the LC-
MS/MS analysis suggested that its absolute abundance must
be quite low. This is addressed further under Discussion
(below).
The results of the Western blotting also indicated that there
was minimal contamination of Cm by incidental lysis. Figure
3 shows the protein profile of 5% of the cells (selected based
on the maximum amount of lysis that may have occurred
according to the results of the G6PD analysis; Figure 1b) to be
markedly distinct from that of the leishmania Cm (compare
Cm with WCL lane 1). The distinct profiles of Cm and WCL
observed in the metabolic labeling experiment (Figure 1a)
also indicated that contamination of Cm through lysis was
negligible.
Gene Ontology analysis of the leishmania secretome
To develop an understanding of how protein secretion by
leishmania might be related to specialized functions or proc-
Leishmania HSPs are enriched in Cm Figure 3
Leishmania HSPs are enriched in Cm. Leishmania conditioned medium 
(Cm) was collected from a culture containing about 2 × 109 promastigotes. 
The proteins contained therein were precipitated and then solubilized 
directly in Laemmli sample buffer. One half of this volume (containing a 
known amount of protein) was loaded into the lane labeled 'Cm'. From the 
2 × 109 promastigotes recovered from the culture, 5% (1 × 108) were 
removed and processed in parallel with the remaining 95%. The 5% figure 
was chosen based upon the estimated (see Figure 1) maximum number of 
organisms that may have undergone incidental lysis during the incubation 
period and the collection centrifugation. Proteins contained in the whole 
cell lysate (WCL) prepared from the 1 × 108 cells were precipitated and 
resolubilized in a volume equal to that used to resolubilize the proteins 
precipitated from Cm collection. To allow for direct comparison to be 
made, half of this volume was then loaded into WCL lane #1. Protein was 
also precipitated from the WCL prepared from the remaining 95% of the 
cells and after solubilization in sample buffer an amount of protein was 
loaded into WCL lane #2 equal to that loaded into the lane labeled Cm. 
After transfer to nitrocellulose membrane, blots were probed, stripped, 
and reprobed with the indicated antibodies. The data shown are 
representative of results obtained in at least three identical experiments. 
EF1alpha, elongation factor-1α; Hsp, heat shock protein; SAcP, secreted 
acid phosphatase.
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esses, we used the Leishmania Genome [29] and the Gene
Ontology (GO) [30] databases in conjunction with the
Blast2GO analysis tool [31] to determine whether any classes
of proteins were more likely to be found in among the leish-
mania secreted proteins. This analysis resulted in 85% of the
proteins detected in leishmania Cm having one or more GO
term assignments (Additional data file 3).
After tallying the number of leishmania secreted proteins
assigned to each GO term, it was clear that many of the
secreted proteins (Figure 4a) were involved in turnover and
synthesis of protein and nonprotein macromolecules. In fact,
27 out of the 151 secreted proteins (18%) were predicted to be
involved in protein translation (GO: 0006412), which was
more than in any other discrete biologic process (Figure 4a).
Beyond this, as shown in Figure 4a, the leishmania secreted
proteins identified by LC-MS/MS were found to be involved
in a wide array of processes, including proteolysis
(GO:0006508), protein folding (GO:0006457), and biologic
regulation (GO:0065007).
Consistent with the biological process GO analysis, a full 50%
of leishmania secreted proteins were involved in protein
binding interactions, for example binding to ATP
(GO:0005524), ions (GO:0043167), or other proteins
(GO:0005515; Figure 4b). Other highly represented functions
included pyrophosphatase activity, hydrolase activity, and
oxidoreductase activity (GO:0016462, GO:0016787, and
GO:0016491). It is noteworthy that nearly 20 proteins that
fell below the secretion cut-off were annotated as having
transporter activity (GO:0005215), whereas no such activity
was found for the secreted proteins (Additional data file 3).
Of interest, there appeared to be a trend toward concentra-
tion of a distinct set of processes and functions in the group of
151 leishmania proteins making up the leishmania secretome.
As shown in Figure 5a, when compared with the total group of
358 proteins consistently identified in Cm, there appeared to
be enrichment of proteins involved in processes related to
growth (GO:0040007), RNA metabolism (GO:0016070), and
biopolymer modification (GO:0043412), including protein
amino acid phosphorylation (GO:0006468). Consistent with
these biologic process assignments, molecular functions such
as kinase activity, peptidase activity, and translation factor
activity (GO:0016301, GO:0008233, and GO:0003746,
respectively) appeared to be more prevalent among the group
of 151 leishmania secreted proteins than among the total
group of 358 proteins consistently identified in Cm (Figure
5b). We used the GOSSIP [32] statistical framework to deter-
mine whether any GO terms were significantly enriched in the
secreted proteins when compared to other Cm proteins. Many
of the processes and functions discussed and depicted in Fig-
ure 5 had significant (P < 0.05) single test P values. However,
after correcting for multiple testing using both a false discov-
ery rate (the most common correction method) and a family
wise error rate (which is more correct in this context because
there was no a priori basis for an association between the
secreted proteins and any GO term) [32], no terms were
found to be significantly enriched in the group of 151 secreted
proteins. This may be due to our small sample size of individ-
ual GO terms associated with at most 358 proteins. In con-
trast, these statistical tests are regularly carried out on sample
sizes in the tens of thousands [32] of genes or proteins. In
addition, statistical significance may not have been achieved
because we were comparing two datasets with a high proba-
bility of overlap, because we looked for enrichment of GO
terms associated with the group of 151 proteins in leishmania
secretome compared with GO terms associated with the total
group of 358 Cm proteins. In fact, some of the Cm proteins
below the cut-off may be actively secreted and certainly were
found to be exported by some mechanism, including cell
death. For these reasons, we consider that the apparent con-
centration of GO associations shown in Figure 5 may in fact
be meaningful.
In addition to members of the secretome having pleiotropic
functions, they were also predicted to have a variety of subcel-
lular localizations. Nearly one-third of leishmania secreted
proteins were predicted to be cytoplasmic (GO:0005737) by
GO, and these had associations with both membrane bound
(GO:0043227) and nonbound intracellular organelles
(GO:0043228), including ribosomal proteins, nuclear pro-
teins, mitochondrial proteins, and glycosomal proteins
(Additional data file 3). Only five secreted proteins were pre-
dicted to be integral membrane proteins, and none of the
secretome proteins were predicted to be associated with the
endoplasmic reticulum.
Bioinformatics analysis of secreted proteins in the 
leishmania genome
We screened the leishmania genome database for proteins
containing a classical amino-terminal secretion signal pep-
tide, in order to generate a putative list of classically secreted
proteins for comparison with the proteins identified by LC-
MS/MS. We modified a bioinformatics approach previously
used to identify proteins secreted by Mycobacterium tuber-
culosis  [33] and applied it to the genome of Leishmania
major  [34]. Proteins were considered highly likely to be
secreted if the sequence included a classical amino-terminal
secretion signal peptide and lacked additional transmem-
brane (TM) domains. Additional TM domains would have
suggested that the protein was membrane bound and there-
fore unlikely to be released from the cell. The majority of
leishmania surface expressed proteins are associated with the
plasma membrane via a glycophosphotidylinositol (GPI) lipid
attachment [9], and some of these GPI-attached surface
proteins, such as GP63, are known to disassociate from the
membrane and can be detected in Cm [35]. In light of this, as
a final step we screened the proteins positive for a signal
sequence and negative for multiple TM domains for GPI-link-
age attachment sites and considered positive proteins to be
secreted (Additional data file 4). Using these parameters, wehttp://genomebiology.com/2008/9/2/R35 Genome Biology 2008,     Volume 9, Issue 2, Article R35       Silverman et al. R35.7
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High prevalence GO assignments in the leishmania secretome Figure 4
High prevalence GO assignments in the leishmania secretome. The secretome sequences were categorized according to (a) biological process and (b) 
molecular function. Nonredundant processes and functions assigned to at least ten leishmania-secreted protein sequences are displayed. Bars indicate the 
number of protein sequences found under each Gene Ontology (GO) term expressed as a percentage of the total 151 actively secreted proteins.
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GO assignments concentrated in the leishmania secretome Figure 5
GO assignments concentrated in the leishmania secretome. (a) Biological process and (b) molecular function Gene Ontology (GO) terms with an 
equivalent or greater number of assignments in the secreted proteins (black bars) compared with all of the conditioned medium (Cm) proteins (white 
bars) are shown. Bars indicate the number of actively secreted protein sequences found under each GO term expressed as a percentage of the 151 
actively secreted proteins (black bars) compared with the total number of Cm sequences found under that GO term expressed as a percentage of the 
total 358 proteins identified in the Cm (white bars).
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found that the leishmania genome encodes 217 proteins that
contain a classical secretion signal peptide, of which 141 are
annotated as hypothetical proteins (Additional data file 4). Of
the remaining 76 proteins, approximately one-third appear to
be gene duplications, leaving 50 unique leishmania proteins
with a known or putative classical eukaryotic secretion signal
peptide. It is of interest that only one of the proteins we pre-
dicted to be secreted via an amino-terminal secretion signal -
LmjF16.0790, a chitinase - has previously been demonstrated
to be secreted by leishmania promastigotes [16,36], although
we did not detect this protein in our LC-MS/MS analysis.
Our analysis also suggests that SAcP does not contain a clas-
sical secretion signal, contrary to a previous report [37].
Based upon the Von Heijne algorithm [34], the latter study
predicted the presence of a 23-amino-acid amino-terminal
'signal peptide'. Subsequently, this leader peptide was shown
to be sufficient for secretion of a green fluorescent protein
fusion construct expressed in L. donovani [27]. The SignalP
algorithm we used is the updated version of the 1985 Von Hei-
jne algorithm. The lack of concordance in these predictions
highlights the limitations of bioinformatics, while reinforcing
the well known fact that signal sequences are highly variable.
Our bioinformatics analysis also confirmed the annotation in
the  Leishmania  G e n o m e  d a t a b a s e  [ 2 9 ]  t h a t  n o n e  o f  t h e
histidine secretory acid phosphatases found in the genomes
of L. major or L. donovani infantum have classical amino-
terminal secretion signals. Interestingly, only the membrane
bound acid phosphatases of L. major are annotated as
containing classical secretion signal peptides, whereas the
same is not true of the orthologs in L. donovani infantum,
and these membrane bound proteins would have been
excluded by our TM domain screen. Only 14 of the proteins
predicted to be secreted through a classical signal sequence-
dependent mechanism were detected in leishmania Cm by
MS, and only two of these, GeneDB:LmjF04.0310 and
LmjF36.3880, had sufficiently high SILAC ratios to be
included in the secretome (Additional data file 4). Although
there are several possible explanations for failing to detect a
protein by LC-MS/MS, the lack of correlation between the
measured and the in silico predicted secretomes suggests that
leishmania utilize nonclassical secretion signals and path-
ways to regulate the export of the majority of secreted
proteins.
Evidence that proteins released by leishmania may 
originate in exosome-like vesicles, apoptotic vesicles, 
and glycosomes
Somewhat unexpected was the finding that leishmania Cm
contained all of the proteins identified previously to be asso-
ciated with exosomes isolated from both B lymphocytes and
dendritic cells, with the exception of those for which the leish-
mania genome does not contain an ortholog (Additional data
file 5). In fact, more than 10% of the proteins found in the
leishmania secretome were previously detected in exosome-
like microvesicles released from other eukaryotic cells (Table
1), including B lymphocytes [38], dendritic cells [24], and adi-
pocytes [39]. Recently, mammalian adipocytes were shown to
secrete microvesicles, which were referred to as adiposomes
[39]. These adiposomes contained 98 proteins, 13 of which we
concluded to be actively secreted (Table 1). At least 25 addi-
tional adiposome proteins were detected in leishmania Cm
with relative abundances lower than the secretome cut-off
(Additional data file 5). The concordance of the proteomic
data between these higher eukaryotic secreted microvesicles
and the leishmania secretome is remarkable. These findings
suggested that leishmania secrete exosome/adiposome-like
microvesicles carrying proteomic cargo that is similar in com-
position to host microvesicles. In support of this, using scan-
ning electron microscopy, we observed 50 nm microvesicles
specifically located at the mouth of the leishmania promastig-
ote flagellar pocket (Figure 6a,b), as well as evenly distributed
across the cell surface of cells with the apparent morphology
of amastigotes undergoing differentiation axenically (Figure
6c).
Microvesicles budding from the flagellar pocket and plasma membrane of leishmania Figure 6
Microvesicles budding from the flagellar pocket and plasma membrane of leishmania. Stationary phase leishmania promastigotes were fixed and coated for 
scanning electron microscopy as described in Materials and methods. (a) A leishmania promastigote, (b) 10× magnification of the exposed flagellar pocket 
region of panel a (square) after stage rotation, and (c) a promastigote in the process of differentiating into an amastigote. Arrowheads point to 
microvesicles.
(a) (c) (b)
5um 500nm 5umGenome Biology 2008, 9:R35
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Surprisingly, DNA-binding histone proteins were reliably
detected by LC-MS/MS in Cm of stationary phase promastig-
otes (Additional data files 1 and 5). Histone proteins have
been detected in dendritic cell exosomal preparations and
were shown to enrich in these preparations after the cells
were treated with an apoptosis-inducing agent [24]. The den-
dritic cell vesicles containing histone proteins were more
electron dense and migrated to a slightly higher sucrose den-
sity than the exosomes [24]. This led the authors to conclude
that the histone-containing vesicles were indeed a distinct
population of vesicles, termed apoptotic vesicles or blebs
[ 2 4 ] .  T h e  d e t e c t i o n  o f  h i s t o n e s  i n  C m  o f  s t a t i o n a r y  p h a s e
leishmania (Additional data files 1 and 5), along with the sig-
nificant number of apoptotic leishmania known to be present
in a stationary phase population (approximately 43 ± 5%)
[25], suggests that promastigotes may have been releasing
apoptotic vesicles as well as exosomes.
In addition to exosomal and apoptotic vesicle-associated pro-
teins, we also found that the leishmania secretome included
many of the major glycolytic enzymes that normally reside in
glycosomes of kinetoplastid organisms [40] (Table 1 and
Additional data file 5). Relevant to these findings, leishmania
have been shown to utilize peroxisomal targeting signals
(PTSs; PTS1 and PTS2) to direct proteins to the glycosome
[41], and a screen of the leishmania genome identified
approximately 100 proteins with either a PTS1 or a PTS2 tar-
geting signal [42]. Remarkably, our MS analysis of leishma-
nia Cm detected nearly half of these predicted glycosomal
proteins, with ten being detected at high enough relative
abundance to be considered bona fide secreted proteins
(Table 1). These findings suggest that leishmania release
either whole glycosomes or glycososomal cargo into the extra-
cellular environment.
Discussion
To our knowledge, this report is the first proteomic analysis of
protein secretion by Leishmania, or, for that matter, any
other kinetoplast. This quantitative proteomic analysis
Table 1
Leishmania-secreted proteins associated with exosome-like and glycosomal vesicles
GeneDB accession number Protein identificationa Mean Cm/CA ratio Microvesicle association
LmjF35.3340 6-Phosphogluconate dehydrogenase, decarboxylating, putative 3.01 GLY
LmjF29.0510 Cofilin-like protein 2.80 DC
LmjF36.6910 Chaperonin, putative, T-complex protein 1 (theta subunit), putative 2.61 AP
LmjF01.0770 Eukaryotic initiation factor 4a, putative 2.60 DC
LmjF28.2860 Cytosolic malate dehydrogenase, putative 2.20 AP
LmjF24.2060 Transketolase, putative 2.19 GLY
LmjF33.2550 Isocitrate dehydrogenase, putative 2.16 AP
LmjF28.2770 Heat-shock protein hsp70, putative 2.14 BC, DC, AP
LmjF35.3860 T-complex protein 1, eta subunit, putative 2.14 AP
LmjF12.0250 Cysteinyl-tRNA synthetase, putative 2.07 GLY
LmjF14.1160 Enolase 2.05 BC, DC, AP
LmjF36.2030 Chaperonin Hsp60, mitochondrial precursor 2.03 AP
LmjF23.1220 T-complex protein 1, gamma subunit, putative 2.00 AP
LmjF05.0350 Trypanothione reductase 1.99 GLY
LmjF36.2020 Chaperonin Hsp60, mitochondrial precursor 1.98 AP
LmjF36.1630 Clathrin heavy chain, putative 1.98 BC, AP
LmjF16.0540 Aspartate carbamoyltransferase, putative 1.95 GLY
LmjF27.2000 Hypothetical protein, conserved 1.90 GLY
LmjF31.1070 Biotin/lipoate protein ligase-like protein 1.89 AP
LmjF26.1240 Heat shock protein 70-related protein 1.86 BC, DC, AP
LmjF04.0960 Adenylate kinase, putative 1.77 GLY
LmjF27.1260 T-complex protein 1, beta subunit, putative 1.76 AP
LmjF30.3240 Glutamyl-tRNA synthetase, putative 1.74 GLY
LmjF21.0810 Methionyl-tRNA synthetase, putative 1.74 GLY
LmjF36.3210 14-3-3 Protein-like protein 1.74 DC, AP
LmjF33.2540 Carboxypeptidase, putative, metallo-peptidase 1.73 GLY
a The Mascot algorithm {2008 609/id} was used to identify the protein names and the GeneDB accession numbers [29]. Microvesicles: BC, B-cell 
lymphocyte exosome [38,62]; DC, dendritic cell exosome [24]; AP, adipocyte exosome (adiposome) [39]; and GLY, leishmania glycosome [42]. CA, 
cell associated; Cm, conditioned medium; Hsp, heat shock protein.http://genomebiology.com/2008/9/2/R35 Genome Biology 2008,     Volume 9, Issue 2, Article R35       Silverman et al. R35.11
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showed that L. donovani released a wide array of proteins
when in the stationary phase of growth (Additional data file
1). Based on previous studies concerned with the pathogene-
sis of leishmania as well as other intracellular pathogens
[17,43], we anticipated that leishmania may secrete virulence
effectors into their extracellular environment, including the
cytosolic compartment of infected host cells. By examining
the composition of the leishmania secretome and generating
quantitative information concerning the relative enrichment
of secreted proteins, we expected to identify candidate leish-
mania effector proteins that may be involved in virulence. As
expected, protein export was found to be heterogeneous, with
some proteins exported to a higher degree than they were
retained by the cell, whereas for others the opposite was true
(Figure 2). It was our assumption that proteins with higher
Cm/CA ratios were more likely to be actively secreted than
they were to be externalized as a result of either incidental
lysis or apoptosis. In light of this, we used the relative abun-
dance data and a rigorous statistical cut-off (Cm/CA values
greater than the ratio for H2B by at least two standard devia-
tions) to define proteins actively secreted by leishmania.
Based on this analysis, we consider 151 proteins in this data-
set to be bona fide members of leishmania secretome. On the
other hand, we recognize that in implementing this rigorous
cut-off we probably sacrificed some sensitivity. Thus, it is
probable that at least some proteins with ratios falling below
the cut-off are actively secreted as well.
Next, we inspected the leishmania secretome for potential
virulence factors. Candidate virulence factors were divided
into four categories: proteins putatively involved in intracel-
lular survival; proteins with known immunosuppressive
functions; proteins involved in signal transduction; and pro-
teins involved with transport processes (Table 2). By far the
largest class of candidate virulence factors was comprised of
proteins that may be required for intracellular survival. The
leishmania secretome showed a remarkable abundance of
proteasome subunits (such as GeneDB:LmjF35.4850,
LmjF36.1600, LmjF21.1700, LmjF21.1830, LmjF27.0190,
LmjF36.1650, and LmjF34.0650) and proteases such as the
oligopeptidases (GeneDB:LmjF09.0770; Tables 2 and 3, and
Additional data file 1), of which many had high Cm/CA val-
ues. In addition, proteolysis was one of the most common GO
terms assigned to the leishmania secreted proteins. Although
the frequency of this term did not reach statistical signifi-
cance (see Gene Ontology analysis of the leishmania secre-
tome, under Results, above), this term appeared to be
somewhat over-represented among the proteins in the upper
half of the ratio distribution (Figures 4a and 5a). It seems
likely that the secretion of at least some of these proteins may
be part of a stress response. On the other hand, some of these
proteins may be involved in pathogenesis. One potential
mechanism is the direction of their proteolytic activities
toward degradative enzymes resident in phagolysosomes to
promote intracellular survival. A second possibility might
involve direction of their proteolytic activities to degrade
major histocompatibility complex class I and II molecules,
thereby preventing antigen loading and reduced efficiency of
antigen presentation, as has been described for leishmania-
infected cells [44]. These findings suggest that secreted leish-
mania proteins with proteolytic activities may contribute to
pathogenesis, and further investigation of this is warranted.
Also likely to be involved in intracellular survival are secreted
antioxidants, and more generally proteins with oxidoreduct-
ase activity, such as iron superoxide dismutase
(GeneDB:LmjF32.1820). Other examples of these were found
in the leishmania secretome (Figure 5b and Additional data
file 1), and these may provide protection from intracellular
free radical attack. In addition, some members of the secre-
tome, such as the putative 14-3-3 protein, are known to have
powerful antiapoptotic properties in other systems [45]. That
leishmania infection inhibits host cell apoptosis is well known
[46,47], and these antiapoptotic secreted proteins may be
active in prolonging the lifespan of infected host cells.
An important inclusion to the category of proteins with func-
tional roles in intracellular survival were nucleases, such as
GeneDB:LmjF23.0200, an endoribonuclease, which was
found to be the second most highly secreted protein (Table 3).
This endoribonuclease belongs to a class of proteins that act
on single-stranded mRNA and are thought to be inhibitors of
protein synthesis [48]. These nucleases may aid in purine
salvage, which is obligatory for leishmania because they are
incapable of de novo purine synthesis [49].
Myo-inositol-1-phosphate synthase (GeneDB:LmjF14.1360),
the protein with the highest relative abundance ratio (Table
3) and therefore the most enriched in the Cm, may also play a
role in intracellular survival (Table 2). Leishmania myo-inosi-
tol-1-phosphate synthase has been shown to be essential for
growth and survival in myo-inositol limited environments
[50]. Leishmania myo-inositol-1-phosphate synthase knock-
outs were found to be completely avirulent [50] in mice, sug-
gesting that the phagolysosomal lumen may be a myo-inositol
limited environment. Myo-inositol-1-phosphate synthase is
required for de novo biosynthesis of myo-inositol, a precursor
of vital inositol phospholipids such as those found in the GPI
membrane anchors of nearly all leishmania surface proteins
and other glycoconjugates such as GP63 and lipophosphogly-
can. The massive export of this essential enzyme into Cm is
intriguing and warrants further study.
The leishmania secreted protein kinetoplastid membrane
protein-11 (GeneDB:LmjF35.2210), identified in the SILAC/
mass spectrometry analysis, was previously characterized as
having immunomodulatory effects on host cells during
leishmania infection [51]. Furthermore, we found that the
leishmania secretome contains an ortholog of the mamma-
lian macrophage migration inhibitory factor
(GeneDB:LmjF33.1750), a protein with known immunosup-
pressive and immunomodulatory properties [52] in humans.Genome Biology 2008, 9:R35
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Table 2
Leishmania candidate virulence factors enriched in Cm
GeneDB accession numbers Protein identificationa Mean Cm/CA
ratiob
Putative functionc
Signal transduction proteins
LmjF35.2420 Phosphoinositide-binding protein, putative 3.51 Kinased
LmjF33.1380 Mitogen-activated protein kinase 11, putative, MAP kinase, putative 2.42 Kinase
LmjF09.0770 Oligopeptidase b, serine peptidase, clan SC, family S9A-like protein 2.31 Cell-cell signaling
LmjF34.2820 Regulatory subunit of protein kinase a-like protein 2.30 Kinase
LmjF28.2740 Activated protein kinase c receptor (LACK) 2.28 Kinase receptor
LmjF25.0750 Protein phosphatase, putative 2.27 Phosphatase
LmjF35.1010 Casein kinase, putative 2.08 Kinase
LmjF10.0490 Mitogen-activated protein kinase 3, putative, MAP kinase 3, putative 1.73 Kinase, signal transduction
LmjF31.2790 ADP-ribosylation factor, putative 1.67 Small GTPase mediated 
signal transduction
Immunosupressive proteins
LmjF35.2210 Kinetoplastid membrane protein-11 2.33 Immunosuppressive [51]
LmjF33.1750 Macrophage migration inhibitory factor-like protein 2.21 Immunosuppressive [52]
LmjF25.0910 Cyclophilin a 1.73 Immunosuppressive [103]
Proteins Involved in Intracellular survival
LmjF14.1360 Myo-inositol-1-phosphate synthase 3.93 Inositol biosynthesis [50]
LmjF23.0200 Endoribonuclease L-PSP (pb5), putative 3.91 mRNA salvage, inhibition 
protein synthesis
LmjF11.0630 Aminopeptidase, putative, metallo-peptidase, clan MF, family M17 3.05 Proteolysis
LmjF28.1730 Proteasome regulatory non-ATP-ase subunit 2, putative 2.40 Proteolysis
LmjF34.1040 Uracil phosphoribosyltransferase, putative 2.34 Pyrimidine salvage
LmjF09.0770 Oligopeptidase b, serine peptidase, clan SC, family S9A-like protein 2.31 Invasion, proteolysis
LmjF32.1820 Iron superoxide dismutase, putative 2.29 Antioxidant
LmjF13.0090 Carboxypeptidase, putative, metallo-peptidase, clan MA(E), family 32 2.14 Proteolysis
LmjF28.2770 Heat-shock protein hsp70, putative 2.14 Protein stability
LmjF26.1570 Thimet oligopeptidase, putative, metallo-peptidase, clan MA(E), family 
M3
2.10 Proteolysis
LmjF05.0960 Dipeptidyl-peptidase III, putative, metallo-peptidase, clan M-, family M49 2.08 Proteolysis
LmjF14.1160 Enolase 2.05 Plasminogen binding [104], 
Invasion
LmjF19.0160 Aminopeptidase, putative, metallo-peptidase, clan MG, family M24 2.04 Proteolysis
LmjF21.1830 Proteasome alpha 5 subunit, putative 2.03 Proteolysis
LmjF05.0350 Trypanothione reductase 1.99 Antioxidant
LmjF21.0760 Proteasome regulatory non-ATP-ase subunit 5, putative,19S 
proteasome regulatory subunit
1.97 Proteolysis
LmjF23.0270 Pteridine reductase 1 1.92 Antioxidant
LmjF26.0810 Glutathione peroxidase-like protein, putative 1.89 Antioxidant
LmjF27.0190 Proteasome alpha 7 subunit, putative 1.89 Proteolysis
LmjF26.2280 Nitrilase, putative 1.86 Carbon-nitrogen 
hydrolase
LmjF26.1240 Heat shock protein 70-related protein 1.86 Protein stability
LmjF31.1890 Peptidase m20/m25/m40 family-like protein 1.85 Proteolysis
LmjF06.0140 Proteasome beta 6 subunit, putative,20S proteasome beta 6 subunit, 
putative
1.85 Proteolysis
LmjF29.0120 Proteasome regulatory non-ATPase subunit, putative 1.81 Proteolysis
LmjF34.0650 Proteasome regulatory non-ATP-ase subunit 11, putative,19S 
proteasome regulatory subunit, metallo-peptidase, Clan MP, Family M67
1.79 Proteolysishttp://genomebiology.com/2008/9/2/R35 Genome Biology 2008,     Volume 9, Issue 2, Article R35       Silverman et al. R35.13
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It is possible that this leishmania ortholog could share these
functions and affect host immune responses during leishma-
nia infection.
Manipulation of host cell function via interference with sign-
aling pathways is a well known virulence tactic of intracellular
pathogens [53-57]. After internalization, leishmania infected
macrophages exhibit defective signaling in response to vari-
ous stimuli [54,55,57]. Based on our analysis, we estimate
that at least ten secreted leishmania proteins are predicted to
be involved in some manner in signal transduction (Table 2
and Additional data file 3). In this regard, we found that
kinase activity was concentrated in the upper half of the
secretome ratio distribution (Figure 5b). Secreted leishmania
signaling intermediates such as the mitogen-activated pro-
tein kinases 3 and 11 (GeneDB:LmjF33.1380 and
LmjF10.0490) and the protein tyrosine phosphatase-like
protein (GeneDB:LmjF16.0230) have the potential to affect
macrophage cell signaling after internalization [56]. Another
interesting signaling related protein, the putative phosphoi-
nositide-binding protein (GeneDB:LmjF35.2420), was one of
most highly secreted proteins (Table 3). This protein might
influence macrophage cell signaling through its potential
binding of inositol containing signaling intermediates that
are products of phosphatidyloinositol 3 kinase. Notably, GO
analysis identified this putative phosphoinositide-binding
protein (GeneDB:LmjF35.2420) as a sorting nexin 4-like pro-
tein (Additional data file 3). Sorting nexins are known to be
involved in coordinating intracellular vesicle trafficking proc-
esses, including both endocytosis and exocytosis [58]. As
such, this putative sorting nexin may be considered to be a
leishmania candidate virulence factor for its potential to
modulate vesicle trafficking in infected cells (Table 2).
Somewhat unexpected was the finding of proteins in leishma-
nia Cm known to be involved in vesicular transport (Tables 2
and 1), such as the phosphoinositide binding protein
discussed above, the small GTP-binding protein Rab1
(GeneDB:LmjF27.0760) and a putative ADP-ribosylation fac-
tor (GeneDB:LmjF31.2790). We have classified these pro-
teins as candidate virulence factors because, although these
transport vesicle regulatory proteins may normally regulate
vesicle trafficking in leishmania, ectopically following secre-
tion, they may have the potential to affect vesicle trafficking in
infected cells. For example, it is tempting to speculate that
these leishmania secreted proteins could directly affect
phagosome maturation through modulating transport to and
fusion with host multivesicular bodies, endosomes, and
lysosomes.
Another interesting and unexpected aspect of the leishmania
secretome was the presence of numerous proteins related to
translational machinery (Figure 4a and Additional data file
3). The functional basis for this is unclear at this time. Per-
haps the turnover of these proteins is extremely high and
excess machinery is disposed of via secretion in addition to
LmjF35.0750 Proteasome activator protein pa26, putative 1.78 Proteolysis
LmjF35.2350 Aminopeptidase P, putative, metallo-peptidase, clan MG, family M24 1.77 Proteolysis
LmjF02.0370 Proteasome regulatory non-ATPase subunit 6, putative 1.77 Proteolysis
LmjF36.3210 14-3-3 protein-like protein 1.74 Anti-apoptotic
LmjF21.1700 Proteasome alpha 2 subunit, putative 1.66 Proteolysis
LmjF36.1600 Proteasome alpha 1 subunit, putative 1.64 Proteolysis
LmjF35.4850 Proteasome alpha 1 subunit, putative 1.60 Proteolysis
Proteins involved in vesicular transport processes
LmjF35.2420 Phosphoinositide-binding protein, putative (sorting nexin 4) 3.51 Transport of proteins and 
other substances
LmjF27.0760 Small GTP-binding protein Rab1, putative 2.27 Endosomes/Golgi 
trafficking
LmjF32.1730 Coatomer epsilon subunit, putative 2.09 Intracellular protein 
transport
LmjF36.1630 Clathrin heavy chain, putative 1.98 Endocytosis, trans-Golgi 
to lysosome trafficking
LmjF18.0700 Hypothetical protein, conserved 1.85 HEAT repeat, intracellular 
protein transport
LmjF31.2790 ADP-ribosylation factor, putative 1.67 Intracellular protein 
transport
aThe Mascot algorithm {2008 609/id} was used to identify the protein names and the GeneDB accession numbers [29]. bMean of normalized, log 
normal (Ln) transformed conditioned medium (Cm)/cell associated (CA) peptide ratios for at least three of four experiments. cPutative functions and 
locations are derived from the GeneDB database {2007 238/id} unless otherwise noted. dProtein sequence contains an amino-terminal secretion 
signal peptide according to SignalP.
Table 2 (Continued)
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the reported processes of ubiquitination and proteasome
mediated degradation. Interestingly, clathrin-coated vesicles
isolated from rat liver [59] were found to contain more than
30 of the same translation related proteins we found in leish-
mania Cm, including a putative leishmania eukaryotic trans-
lation initiation factor 1A (GeneDB:LmjF16.0140), the
protein with the fifth highest enrichment ratio (Table 3).
Appreciation of the multifunctional nature of proteins is
increasing, and the possibility exists that these proteins, per-
haps purposely packaged in leishmania secretory vesicles,
may play ancillary roles in pathogenesis or pathogen survival,
similar to what appears to be the case for EF-1α [17].
The protein secretion pathways utilized by leishmania are not
well understood. According to our analysis, only two of the
151 proteins in the leishmania secretome contain a classical
amino-terminal secretion signal (Additional data files 2 and
4). The fact that more than 98% of the secretome lacks a tar-
geting signal indicates that nonclassical secretion pathways
are probably the dominant means by which leishmania pro-
teins are secreted. In support of this argument, the leishma-
nia secretome included a large number of proteins previously
identified as components of exosomes secreted from various
higher eukaryotic cell types (Table 1). Leishmania Cm also
contained many proteins shown to be cargo of clathrin-coated
vesicles. Rat liver clathrin-coated vesicles were found to con-
tain a total of 346 proteins, and in addition to the 30 transla-
tion-related proteins mentioned above, an further 30 of these
proteins were detected in leishmania Cm, including clathrin
(GeneDB:LmjF36.1630) and HSP70. Significantly, both
clathrin and HSP70 have been found in exosomes released
from various human cells [24,38,39]. In fact, the proteomes
of these clathrin-coated vesicles and that of mammalian exo-
somes were strikingly similar [24,59-62]. Furthermore, leish-
mania have been shown to form clathrin-coated vesicles [63],
and clathrin-directed trafficking in leishmania was shown to
be essential for survival in macrophages [64]. Taken together,
these findings suggest that leishmania may use clathrin-
coated vesicles as a transport mechanism to direct vesicle
trafficking at least, if not exocytosis of proteins from endo-
somal compartments to the extracellular milieu. Based on
these findings, we propose that leishmania protein secretion
probably involves the release of exosome-like vesicles, which
may or may not be clathrin-coated. Moreover, we suggest that
at least three distinct vesicular secretion processes contribute
to the secretome, including exosomes, apoptotic vesicles, and
glycosomes (Table 1).
Exosomes are small vesicles, 50 to 100 nm in diameter, which
are released by fusion of either multivesicular endosomes or
secretory lysosomes with the plasma membrane of eukaryotic
cells [65-67]. Exosomes were initially described in reticulo-
cytes as a mechanism for shedding organellar proteins and
excess transferrin receptor during differentiation into mature
nuclei free red blood cells [68]. Somewhat later, the pro-
teomes of B lymphocyte and dendritic cell exosomes were
described [24,38]. Dendritic cell exosomes have attracted a
significant amount of attention because of their immunostim-
ulatory properties as cell-free, peptide-based vaccines [69-
72]. The striking correspondence between the leishmania
secretome and these exosomes strongly suggests that protein
secretion by leishmania involves the release of intraluminal
vesicles originating from either the tubular lysosome [73] or
multivesicular endosomes, or both. It is tempting to speculate
Table 3
Highly enriched leishmania secreted proteins
GeneDB accession number Protein identificationa Mean Cm/CA
ratiob
Functionc Predicted 
locationc
LmjF14.1360 Myo-inositol-1-phosphate synthase 3.93 Inositol biosynthesis [50] Cytosol
LmjF23.0200 Endoribonuclease L-PSP (pb5), putative 3.91 Nuclease, mRNA cleavage Cytosol
LmjF15.1203 60S acidic ribosomal protein P2 3.73 Translation [102] Ribosomed
LmjF35.2420 Phosphoinositide-binding protein, putative 3.51 Phosphoinositol binding, signal 
transduction
Cytosold
LmjF16.0140 Eukaryotic translation initiation factor 1A, 
putative
3.26 Translation Cytosol, 
exosomes 
[24,38,39]
LmjF32.2180 Hypothetical protein, conserved 3.08 Translation initiation Nucleus
LmjF11.0630 Aminopeptidase, putative, metallo-peptidase, 
Clan MF, Family M17
3.05 Proteolysis Cytosol
LmjF35.3340 6-Phosphogluconate dehydrogenase, 
decarboxylating, putative
3.01 Glucose cataboloism Cytosol
LmjF04.0310 Beta-fructofuranosidase, putative 2.93 Carbohydrate metabolism Cytosold
LmjF36.3840 Glycyl tRNA synthetase, putative 2.87 Translation Cytosol
aThe Mascot algorithm {2008 609/id} was used to identify the protein names and the GeneDB accession numberes [29]. bMean of normalized, log 
normal (Ln) transformed conditioned medium (Cm)/cell associated (CA) peptide ratios for at least three of four experiments. cPutative functions and 
locations are derived from the GeneDB database {2007 238/id}unless otherwise noted. *Protein sequence contains an amino-terminal secretion 
signal peptide according to SignalP.http://genomebiology.com/2008/9/2/R35 Genome Biology 2008,     Volume 9, Issue 2, Article R35       Silverman et al. R35.15
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that leishmania exosomes, like dendritic cell exosomes
[69,70], may be capable of modulating the host immune
response, although it likely that their properties may be quite
distinct.
The formation of membrane blebs at the plasma membrane
of apoptotic mammalian cells and their subsequent release
are phenomena that have attracted significant attention
[24,66,74]. As mentioned above, these apoptotic vesicles have
been found to contain histone proteins and cytochrome c oxi-
dase subunits. That leishmania undergo apoptosis is well
established [25], and our finding that they release cyto-
chrome c oxidase subunits and histones into Cm (Additional
data files 1 and 5) suggests that they release apoptotic vesi-
cles. Moreover, it has been shown that cultures of stationary
phase leishmania promastigotes contain up to 43% apoptotic
cells, and when the latter are removed by sorting the remain-
ing nonapoptotic population is incapable of establishing and
maintaining an infection [25]. These findings, taken together
with our detection of apoptotic vesicle marker proteins, his-
tones 1 through 4, in leishmania Cm (Additional data files 1
and 5), strongly suggest the possibility that leishmania apop-
totic vesicles may be involved in pathogenesis. This could take
the form of immune evasion, wherein (similar to activation of
the 'silent phagocytosis' pathway used to internalize and clear
very early apoptotic cells by mammalian macrophages [75])
these apoptotic vesicles would promote inhibition of macro-
phage activation before invasion by viable leishmania
promastigotes.
Somewhat more difficult to explain from our findings is the
suggestion for whole glycosome release, based upon both the
characterized and the putative glycosomal proteins we
detected in leishmania Cm (Table 1). Notably, many of the
leishmania Cm proteins that were bioinformatically predicted
to be glycosomal by the presence of PTS1 or PTS2 have been
identified in purified glycosomes of the closely related kineto-
plast Trypanosoma brucei brucei [76]. Our identification of
the two most prevalent leishmania glycosomal membrane
proteins in promastigote Cm (Additional data file 5) suggests
that intact glycosomes were being exported from the cell. This
is as opposed to a model in which these organelles were fusing
with the flagellar pocket to release their cargo, in which case
w e  w o u l d  n o t  h a v e  e x p e c t e d  t o  h a v e  d e t e c t e d  g l y c o s o m a l
membrane proteins per se. As we suggested above to poten-
tially explain the secretion of translation machinery proteins,
release of glycosomal proteins may be related to a stress
response, but the targeted release of glycosomes with a more
specialized function remains a possibility.
As previously stated, it is our hypothesis that the proteins
with higher relative abundance in leishmania Cm are more
likely to play an active role in pathogenesis than those pro-
teins secreted to a lesser extent. Following this logic, export of
proteins with lower Cm abundance may be related to either
routine waste disposal or apoptotic blebbing, and these may
be less likely to contribute to pathogenesis. Although this is a
reasonable working model, it is not absolute and does not
mean that proteins secreted in lesser abundance may not be
of interest. In fact, EF-1α, a candidate virulence factor that
has been shown to inhibit macrophage activation [17], had a
Cm/CA peptide ratio in the lowest 20% of the ratio distribu-
tion (Figure 2, and Additional data files 2 and 5), and well
below the cut-off for active secretion used to define the secre-
tome. These data, especially when combined with the findings
that apoptotic leishmania are required for leishmania disease
development [25], support the interpretation that many of
the proteins found in leishmania Cm are potential candidates
for unique and essential roles in leishmania virulence, and
further analysis will be required to prioritize those that
should receive additional attention.
It should be mentioned that three leishmania proteins previ-
ously described to be secreted, namely SacP [14], chitinase
[36], and silent information regulator (SIR)2 [18], were not
identified in this LC-MS/MS analysis of leishmania Cm. One
possible explanation for why these identifications were not
made is that they have extremely low intracellular concentra-
tions, with nearly all of the synthesized protein being
secreted. Under these conditions other proteins present in the
cell at a higher concentration could mask the CA peptide sig-
nals in the mass spectrometry. Importantly, the SILAC/mass
spectrometry analysis was designed to compute ratios of
simultaneously detected spectra from mixed Cm and CA sam-
ples. The absence of a CA signal in the mass spectrometry
would have provided a denominator of zero, thereby not
allowing for the computation of a meaningful Cm/CA ratio
and exclusion from the analysis. Thus, no matter how abun-
dant these peptides might be in Cm, without a comparable CA
signal these proteins would not be included in the leishmania
secretome, as defined by this study. It is possible that this
explanation may also account for why chitinase and SIR2
were not identified in the secretome, especially considering
that neither have characterized intracellular functions.
Finally, we conducted these experiments using L. donovani
donovani. Sequencing of the L. donovani genome is currently
underway. As such we used the completed L. major genome
to assign protein identities to the mass spectra gathered from
leishmania Cm. Although the genomes for these two species
are thought to be very similar, as their similar life cycles, biol-
ogy, and expression profiles would indicate [77], it is possible
that genomic difference between species prevented identifi-
cation of some Cm proteins.
Examination of the secretome led to several additional find-
ings worth noting. First, the number of proteins known to be
associated with small vesicles outstripped by far the number
of proteins identified that had classical secretion signals. This
finding suggests that the main secretory route for leishmania
involves the release of small vesicles. Second, for the majority
of candidate virulence factors that were identified, it seems
most likely that they may function to influence the survival ofGenome Biology 2008, 9:R35
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leishmania within the phagolysosome, although this remains
to be formally tested. As the collection time for Cm was lim-
ited because of the need to culture organisms in the absence
of serum, proteins in the secretome that may be involved in
pathogenesis are likely to act during early stages of infection.
During this early stage, they may contribute to the observed
delay of phagosome maturation [78]. It has been proposed
that delayed phagosome maturation represents a window of
opportunity during which internalized promastigotes can dif-
ferentiate into the more acid-tolerant amastigotes [79,80].
Whether the amastigote secretome is similar to or distinct
from that of stationary phase promastigotes is not known at
this time. However, given the relatively low stage-specific dif-
ferences in gene expression that have been described [81], we
do not regard significant differences to be likely. Third, tar-
geting of virulence factors into host cell cytosol has been
shown to be an effective strategy used by intracellular patho-
gens to remodel the environment and to influence host cell
function [17,82-85]. After invading their macrophage hosts,
leishmania have been shown to block cell activation, to inhibit
microbicidal activity [86-88], and to attenuate antigen-pre-
senting cell function [57,89,90]. A broad picture of the pro-
teins secreted by leishmania in cell free culture provides a
basis for investigation of effector proteins that may be active
in host cells either within the phagolysosome or within host
cytosol.
Conclusion
This quantitative proteomic analysis identified a large and
diverse pool of proteins in leishmania Cm and allowed us to
define the leishmania secretome based on measurements of
r e l a t i v e  p r o t e i n  a b u n d a n c e  i n  C m  t h a t  c o u l d  o n l y  b e
explained by active secretion. The identities of proteins
within the secretome revealed many candidates for further
studies concerned with potential contributions to virulence
and pathogenesis as well as to investigate mechanisms of
secretion. Moreover, the data also indicate clearly that leish-
mania use predominantly nonclassical targeting mechanisms
to direct protein export. This leads us to propose a model in
which protein export occurs largely through the release of
microvesicles, perhaps including exosome-like vesicles,
apoptotic vesicles, and glycosomes.
Materials and methods
Cell culture
L. donovani Sudan strain 2S promastigotes were cultured in
medium M199 supplemented with 10% fetal bovine serum
(FBS; Gibco Cell Culture, Div. of Invitrogen Life Technolo-
gies, Gaithersburg, MD, USA), 1% penicillin and streptomy-
cin, 20 mmol/l HEPES (Stem Cell Technologies, Vancouver,
British Columbia, Canada), 6 μg/ml hemin, 2 mmol/l L-
glutamine, 10 μg/ml folic acid, and 100 μmol/l adenosine at
26°C in a EchoTherm Chilling Incubator (Torrey Pines Scien-
tific, San Marcos, CA, USA). Every third day the organisms
were split 1:10 into fresh medium in 25 or 75 cm3 cell culture
flasks. For SILAC analysis, promastigotes were transferred to
custom made M199 without L-arginine and L-lysine (Caisson
Laboratories, North Logan, UT, USA) supplemented with
10% partially dialyzed FBS (Gibco), 1% penicillin and strepto-
mycin, 20 mmol/l HEPES (Stem Cell Technologies), 6 μg/ml
hemin, 2 mmol/l L-glutamine, 10 μg/ml folic acid, 100 μmol/
l adenosine, and one of two SILAC media formulations (nor-
mal isotopic abundance arginine [42 mg/l] and lysine [73
mg/l]; and 13C6-arginine [43.5 mg/l] and 2H4-lysine [75 mg/
l]) at 26°C. Organisms were cultured in this medium for at
least 14 days and split 1:10 every third day, in order to achieve
100% labeling of cellular proteins before analysis. Stable iso-
tope-labeled amino acids were purchased from Cambridge
Isotope Laboratories (Andover, MA, USA). Except where oth-
erwise noted, reagents were obtained from the Sigma-Aldrich
Chemical Company (St. Louis, MO, USA).
Isolation of promastigote Cm
Stationary phase promastigotes that had been grown either in
medium containing normal isotopic abundance arginine and
lysine or in medium containing 13C6-arginine  2H4-lysine L
were collected by centrifugation at 300 × g for 10 minutes in
a Beckman GS-6R centrifuge (Beckman-Coulter, Fullerton,
CA, USA) and washed in Hanks balanced salt solution.
Organisms were then concentrated tenfold by re-suspension
in medium M199 without FBS and supplemented with 2
mmol/l L-glutamine, 10 mmol/l HEPES, 10 μg/ml soya bean
trypsin inhibitor (Sigma-Aldrich), and either normal isotopic
arginine and lysine or 13C6-Arg and 2H4-Lys in the concentra-
tions given above for 4 to 6 hours at 26°C. Cm was isolated
from cells by centrifugation at 300 × g for 10 minutes in a
Beckman GS-6R. Supernatant was then subjected to centrifu-
gation once more to ensure that no cells remained in suspen-
sion. Cm and cell pellets were either used immediately for
enzymatic analysis or stored at -20°C for mass spectrometry
analysis. A minimum of 5 × 108 promastigotes in culture was
required to generate Cm with signals of adequate strength for
mass spectrometry analysis.
Four times as many stationary phase organisms were
required to generate sufficient Cm for detection of proteins by
either metabolic labeling and autoradiography or by Western
blotting. Two billion organisms were cultured in M199 con-
taining normal isotopic arginine and lysine (Sigma-Aldrich).
For autoradiography, cells were collected and washed as
above, and then starved of methionine by resuspension in
RPMI-1640 medium without methionine and cysteine
(Sigma-Aldrich) with 1% FBS. After 1 hour 50 μCi/ml of 35S
methionine (Sigma-Aldrich) was added and cells were cul-
tured for a further 2 hours to allow labeling to occur. After
washing to remove serum, cells were incubated for 4 hours in
serum-free RPMI-1640 medium without methionine and
cysteine, containing 10 mmol/l L-glutamine, 1 mmol/l
HEPES, and 10 μg/μl Soya bean trypsin inhibitor, at which
point the cells were separated from the Cm by low speed cen-http://genomebiology.com/2008/9/2/R35 Genome Biology 2008,     Volume 9, Issue 2, Article R35       Silverman et al. R35.17
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trifugation to avoid mechanical lyses of cells. Pelleted cells
were lysed on ice in lysis buffer (50 mmol/l Tris [pH 7.4], 1%
Triton X-100, 0.15 mol/l NaCl, 1 mmol/l EGTA, 1 mmol/l
phenylmethylsulfonyl fluoride, 10 μg aprotinin/ml, and 10 μg
leupeptin/ml). Cell lysates were clarified by centrifugation in
a microcentrifuge at maximum speed for 20 min at 4°C. The
resulting WCL supernatants and the Cm were precipitated
with trichloroacetic acid at 10% final concentration. The pre-
cipitates were solubilized in Laemmli sample buffer and equal
counts/minute of Cm and WCL were separated by SDS-PAGE
(5% to 20% gradient) followed by autoradiography.
For Western blotting, Cm was collected as above, but organ-
isms were concentrated in normal isotopic M199. After sepa-
rating Cm from the cells, WCLs were generated by sonicating
the cell pellets to mimic lysis that may have occurred inad-
vertently during culture or centrifugation. Briefly, cell pellets
were solubilized in 0.5 mmol/l Tris Laemmli sample buffer
without SDS, bromophenol blue, or β-mercaptoethanol, but
including protease inhibitors leupeptin and aprotinin both at
1 μg/ml and 10 μg/ml phenylmethylsulphonyl fluoride. The
solution was sonicated three times at a power setting of 3 for
10 seconds. The lysate was cleared of insoluble material by
centrifugation for 5 minutes at 10,000 × g. Following clarifi-
cation the supernatant proteins were precipitated following
the procedure bellow. The pellet was resuspended in Laemmli
sample buffer without β-mercaptoethanol or bromophenol
blue.
Protein precipitation
For Western blotting and metabolic labeling analysis, pro-
teins present within promastigote Cm were precipitated using
pyrogallol red, as described previously [91]. Briefly, sodium
deoxycholate was added to Cm to a final concentration of
0.02% and the solution was mixed for 30 minutes at 4°C to
facilitate precipitation. Cm was then mixed with an equal vol-
ume of pyrogallol red solution (containing 0.05 mmol/l pyro-
gallol red, 0.16 mmol/l sodium molybdate, 1.0 mmol/l
sodium oxalate, 50 mmol/l succinic acid, and 20% methanol
[vol/vol]) and the pH adjusted to 2.0 with 2N HCl. The result-
ing solution was incubated at room temperature for 1 to 2
hours followed by 12 to 24 hours at 4°C. The Cm protein pre-
cipitates were harvested by centrifugation at 11,000 × g for 60
minutes at 4°C followed by two washes with ice cold acetone.
The pellets were allowed to air dry before solubilization in
Laemmli sample buffer without β-mercaptoethanol or
bromophenol blue at 95°C for 30 minutes. Protein concentra-
tions of the Cm and WCLs were measured using the BioRad
DC Protein Assay (BioRad Laboratories Inc., Hercules, CA,
USA).
G6PD assay
Promastigote cell pellets were lysed by sonication to generate
a WCL in 1 ml medium M199 with the appropriate concentra-
tions of either normal isotope or nonradioactive isotope
arginine and lysine, 1 mmol/l L-glutamine, 1 mmol/l HEPES,
10 μg/ml soya bean trypsin inhibitor, protease inhibitors leu-
peptin and aprotinin both at 1 μg/ml, and 10 μg/ml phenyl-
methylsulphonyl fluoride. After clearance by centrifugation
at 11,000 × g, serial twofold dilutions of the lysate were made
in medium M199 supplemented as above to yield final con-
centrations of 50%, 25%, 10%, 5%, and 1% (vol/vol). The con-
centrations of G6PD in 100 μl of Cm and in serial dilutions of
WCL were assayed in 55 mmol/l Tris-HCl and 3.3 mmol/l
MgCl2 buffer at pH 7.8, containing 3.3 mmol/l glucose-6-
phosphate and 2 mmol/l NADP. Enzyme was obtained from
the Sigma Chemical Company for a positive control. To gen-
erate a reference, 0.01 units of G6PD were stabilized in 5.0
mmol/l glycine with 0.01% bovine serum albumin (pH 8.0)
and assayed along with sample and WCL dilutions. Enzyme
reactions were carried out at 30°C and the change in absorb-
ance, caused by changing NADP concentration, over 5 min-
utes was measured at 340 nm.
LC-MS/MS of promastigote conditioned medium and 
data analysis
To identify proteins specifically secreted by leishmania into
culture medium, direct quantitative comparisons of protein
abundance in Cm versus CA were made on a protein-by-pro-
tein basis. The Cm was collected from leishmania grown in
medium containing heavy isotopes of arginine and lysine, and
compared with cell-associated material prepared from pro-
mastigotes grown in medium containing normal isotopic
abundance amino acids. In some cases the reciprocal analysis
was also carried out as well with identical results.
Approximately equal amounts of labeled and unlabeled pro-
tein (estimated from a preliminary LC-MS/MS analysis) from
Cm and CA were mixed together and analyzed either by gel-
enhanced LC-MS/MS exactly as described previously [92] or
by peptide-level isoelectric focusing (IEF) combined with LC-
MS/MS. For IEF, the protein mixture was solubilized in
digestion buffer (50 mM NH4OH, 1% sodium deoxycholate,
pH 8.0), denatured by heating to 99°C for 5 minutes, reduced
by incubation with 1 μg dithiothreitol for 30 minutes at 37°C,
alkylated with 5 μg iodoacetamide for 30 minutes at 37°C and
finally digested by the addition of 1 μg porcine trypsin
(Promega, Madison, WI, USA) overnight at 37°C. After diges-
tion, the sample was acidified by addition of an equal volume
of sample buffer (3% acetonitrile, 1% trifluoroacetic acid, and
0.5% acetic acid) and the deoxycholate that fell out of solution
was pelleted at 16,100 × g for 5 minutes. Peptide mixtures
were then desalted on STop-And-Go Extraction (STAGE) tips
[93] before being resolved into 24 fractions from pH 3 to 10
on an OFFGEL IEF system (Agilent Technologies, Santa
Clara, CA, USA), in accordance with the manufacturer's
instructions. Fractions from the IEF were diluted with an
equal volume of sample buffer, and each was desalted again
on a STAGE tip. Each gel or OFFGEL fraction was analyzed
on a linear trapping quadrupole-Fourier transform tandem
mass spectrometer, as described previously [19]. Fragment
spectra were extracted with ExtractMSN.exe (v3.2) using theGenome Biology 2008, 9:R35
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default parameters (ThermoFisher Scientific, Ottawa, ON,
CA); monoisotopic peak assignments were corrected with
DTASuperCharge (default parameters [94]); and the result-
ing peak list was searched against the protein database for L.
major plus the sequences of all human keratins and porcine
trypsin (5 November 2006 version, 8,324 sequences) using
Mascot (v2.1 [95]).
MSQuant [94] was used to parse Mascot result files, to recal-
ibrate mass measurements, and to extract quantitative ratios.
The final nonredundant list of proteins was generated using
finaList.pl, an in-house script available on our website [96].
The false discovery rate for protein identifications based on
two or more peptides with a measured mass accuracy under 3
ppm (the overall average was 0.61 ppm), a Mascot score of 25
or greater, and length 8 residues or more was estimated to be
less than 0.5%, using reversed database searching. All identi-
fied peptides with their associated parameters can be found in
Additional data file 1. SILAC ratios were extracted exactly as
described previously [19]. The mean loge transformed ratios
from four independent analyses and the relative standard
deviations can be found in Additional data file 2.
Western blotting
Following isolation of Cm, lysis of the corresponding cell pel-
let, and precipitation of proteins in both fractions, equivalent
amounts of protein from the Cm and WCL were fractionated
by SDS-PAGE. Proteins were transferred to nitrocellulose
and probed with anti-EF-1α (Upstate Biotechnologies Inc.,
Lake Placid, NY, USA) following the manufacturer's
instructions, as well as leishmania-specific antibodies to his-
tidine secreted acid phosphatase [97] and against HSP70 and
HSP90 [98] (a kind gift from Dr Joachim Clos).
Scanning electron microscopy
Stationary phase promastigotes were washed in phosphate-
buffered saline and fixed in 2.5% gluteraldehyde in 0.1 mol/l
sodium cacodylate buffer (pH 7.2) containing 0.146 mol/l
sucrose and 5 mmol/l CaCl2 at 22°C under vacuum in a micro-
wave: 2 minutes at 100 W, 2 minutes without microwaves, 2
minutes with 100 W, and then repeated. Subsequently, fixed
organisms were rinsed in the same buffer in the microwave
for 40 seconds at 100 W two times and post-fixed in 1% OsO4
in 0.1 mol/l sodium cacodylate containing 2 mmol/l CaCl2
and 0.8% potassium ferricyanide (Polysciences, Warrington,
PA, USA) at 22°C under vacuum in a microwave following the
same steps used in the gluteraldehyde fixation. Cells were
washed in distilled water at room temperature and allowed to
adhere to poly-L-lysine (Sigma) coated coverslips. Subse-
quently the coverslips were dehydrated through an ascending
ethanol series from 50% to 100%, each for 40 seconds at 100
W in a microwave. The fixed cells were critically point dried
with liquid CO2 in a Balzars 020 Critical Point Dryer (Balzars
Union Ltd, Lichtenstein) and coated with gold palladium
using a Nanotech SEMPrep II sputter coater (Nanotech Ltd.,
Prestwick, U.K.). Samples were observed and imaged using a
Hitachi S-2600 VPSEM (Hitachi High Technologies, Fin-
champstead, Wokingham, Berkshire, UK) at the University of
British Columbia Bioimaging Facility.
Bioinformatics screen of the genome of Leishmania 
major to identify candidate secreted proteins
The genome of L. major was accessed at the GeneDB L. major
database [29]. Predictions of signal peptides and signal pepti-
dase cleavage sites were made by SignalP [99]. Once these
were provisionally identified, a filter was applied to remove
those that contained more than one TM region predicted by
TMpd [100]. Proteins with just one TM region were again
screened to filter out those whose single TM domain did not
overlap with the signal peptide coordinates. Finally, these
putative classically secreted, non-TM proteins were screened
for GPI attachment sites at the carboxyl-terminus using the
GPI prediction program GPI-SOM [101].
Gene Ontology
GO [30] annotations were performed using Blast2GO [31]. A
nonredundant database was used as reference for Blastp
searches with an expectation value minimum of 1 × e-3 and a
high scoring segment pair cut-off of 33. Annotations were
made with default parameters. Briefly, the pre-eValue-Hit-
Filter was 1 × e-6, the Annotation cut-off was 55, and the GO
Weight was 5. The statistical framework GOSSIP [32] was
used to identify statistically enriched GO terms associated
with leishmania secreted proteins when compared to the GO
terms associated with all of the proteins identified in leshma-
nia Cm. GOSSIP generates 2 × 2 contingency tables for each
GO term in the test group and uses a Fisher's exact test to cal-
culate P values for each term. The P values are then adjusted
for multiple testing by calculation of the false discovery rate
and the family wise error rate [32].
Statistical analysis
Statistical analyses of Cm/CA ratios and G6PD concentra-
tions were performed using GraphPad Prism version 4.00 for
Windows (GraphPad Software, San Diego, CA, USA).
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tion factor-1α; FBS, fetal bovine serum; G6PD, glucose 6-
phosphate dehydrogenase; GO, Gene Ontology; GPI, glyco-
phosphotidylinositol; HSP, heat shock protein; IEF, isoelec-
tric focusing; LC-MS/MS, liquid chromatography-tandem
mass spectrometry; PTS, peroxisomal targeting signal; SacP,
secreted acid phosphatase; SILAC, stable isotopic labeling of
amino acids in culture; SIR, silent information regulator; TM,
transmembrane; WCL, whole cell lysate.
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Additional data files
The following additional data files are available with the
online version of this paper. Additional data file 1 is a table
listing all the proteins, and the peptides contributing to their
identification, detected in leishmania Cm. Additional data file
2 is a table showing a complete list of the SILAC ratios calcu-
lated for each Cm protein in each experiment, including the
means of the four experiments. Additional data file 3 is a table
listing all the GO terms associated with the leishmania Cm
proteins. Additional data file 4 is a table listing the proteins
predicted by bioinformatics to be secreted under the control
of an amino-terminal secretion signal peptide; also shown
here are the proteins with predicted GPI attachment sites and
those proteins determined to be present in leishmania Cm by
the SILAC LC-MS/MS analysis. Additional data file 5 is a
table listing the leishmania Cm proteins, their mean SILAC
ratios, and any documented microvesicle associations for
these proteins.
Additional data file 1 The proteome of leishmania Cm 358 proteins had at least two nonoverlapping peptides that were  detected and quantified in three or more individual analyses of  leishmania Cm proteins. The peptides corresponding to each iden- tification are shown. Protein identities were determined as  described in Materials and methods and for Tables 1 to 3. Click here for file Additional data file 2 Cm/CA peptide ratios of leishmania Cm proteins After determining which proteins were to be considered for analy- sis (as described in Materials and methods and for Additional Data  File 1), the measured Cm/CA ratios were normalized to the meas- ured value of histone H2B in each independent experiment. The  normalized values were then log normal (Ln) transformed (mean  Ln transformed Cm/CA ratio, experiments [Exps] 1 to 4) to reduce  the spread of the data. The means of the Ln transformed ratios for  each protein identity were then calculated (mean Ln transformed  values). The relative standard deviations of the peptide ratios for  each analysis are included. Click here for file Additional data file 3 GO analysis of leishmania Cm proteins GO annotation of the proteins detected in leishmania Cm. *Pro- teins with amino-terminal secretion signal peptides, and †proteins  shown to be antigenic. GO IDs lists the GO identification number  associated with each protein, and GO Term lists the term associ- ated with each GO ID. C, cellular compartment; F, molecular func- tion; P, biologic process. Click here for file Additional data file 4 Bioinformatics analysis of classically secreted leishmania proteins Leishmania proteins predicted to be classically secreted by a  genome wide screen for proteins containing an amino-terminal  secretion signal peptide. MS, proteins detected in the SILAC/mass  spectrometry analysis; § proteins detected by mass spectrometry  with ratios above the secretome cut-off; GPI, proteins found to con- tain a GPI attachment site; *, proteins previously reported to be  secreted by leishmania. Click here for file Additional data file 5 Microvesicle associations of leishmania Cm proteins Proteins with mean Cm/CA peptide ratios greater that two stand- ard deviations above that of histone H2B were considered  enriched. *Proteins with amino-terminal secretion signal peptides,  and †proteins shown to be antigenic. Microvesicle Association dis- plays the vesicles associated with the protein ID. AP, adipocyte adi- posome; BC, B-cell lymphocyte exosome; DC, dendritic cell  exosome; Gly, glycosome. Click here for file
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